location： Current position: Home-Yong Liu >> Scientific Research >> Paper Publications

Higher risk of hepatotoxicity associated with cabozantinib in cancer patients

Hits:

Date of Publication:2024-04-25

Journal:CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Volume:196

ISSN No.:1040-8428

Key Words:ACUTE HEPATITIS; KINASE INHIBITORS; MANAGEMENT; OPEN-LABEL; ORAL MEDICATIONS; PLUS CABOZANTINIB; REACTIVE METABOLITES; RENAL-CELL CARCINOMA; SORAFENIB; SUNITINIB

Pre One:Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactions.

Next One:Potential risk of drug-drug interactions of ponatinib via inhibition against human UDP-glucuronosyltransferases.
Recommended Ph.D.Supervisor Recommended MA Supervisor Institutional Repository Personal Page

Address: No.2 Linggong Road, Ganjingzi District, Dalian City, Liaoning Province, P.R.C., 116024

Click : times
  • MOBILE Version
    •
    Open time:..
    The Last Update Time:..

    Mobile phone sweep